![A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck - A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/86877c4b-5786-4f48-ab24-a92986c64ffd/gr1.jpg)
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck -
![Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study∗ - Clinical Breast Cancer Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study∗ - Clinical Breast Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/32dd041a-6686-4f37-a86a-89ffc462827a/gr1_lrg.jpg)
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study∗ - Clinical Breast Cancer
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from b
![Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study - Journal of Pain and Symptom Management Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study - Journal of Pain and Symptom Management](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/617dbcc4-0e88-4216-afa0-0d938c21c541/gr2_lrg.jpg)
Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study - Journal of Pain and Symptom Management
![Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma | Journal of Laparoendoscopic & Advanced Surgical Techniques Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma | Journal of Laparoendoscopic & Advanced Surgical Techniques](https://www.liebertpub.com/cms/10.1089/lap.2020.0559/asset/images/medium/lap.2020.0559_figure1.jpg)
Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma | Journal of Laparoendoscopic & Advanced Surgical Techniques
![Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places](https://www.researchgate.net/publication/350121301/figure/tbl1/AS:1010804438609920@1618005966478/Anti-cancer-treatment-in-SARS-CoV-2-infected-cancer-patients_Q320.jpg)
Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places
![Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group - Annals of Oncology Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b5535013-b63a-4943-9c1e-c0a250730483/gr1.jpg)
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group - Annals of Oncology
![Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study - Journal of Pain and Symptom Management Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study - Journal of Pain and Symptom Management](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b738e816-0654-41de-89c6-ab66ab39d0e2/gr1.jpg)
Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study - Journal of Pain and Symptom Management
![Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study - The Breast Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study - The Breast](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e82ff8be-26b4-442b-97e6-4ca9cb217749/gr3_lrg.jpg)
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study - The Breast
![Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places](https://www.researchgate.net/publication/350121301/figure/tbl3/AS:1010804438605828@1618005966555/Cont_Q320.jpg)
Gabriella Farina's research works | Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano (Fatebenefratelli) and other places
![Nutrients | Free Full-Text | The Clinical Value of Nutritional Care before and during Active Cancer Treatment | HTML Nutrients | Free Full-Text | The Clinical Value of Nutritional Care before and during Active Cancer Treatment | HTML](https://www.mdpi.com/nutrients/nutrients-13-01196/article_deploy/html/images/nutrients-13-01196-ag.png)
Nutrients | Free Full-Text | The Clinical Value of Nutritional Care before and during Active Cancer Treatment | HTML
![Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-019-0584-5/MediaObjects/41416_2019_584_Fig1_HTML.png)